<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Taurog JD</submitter><funding>NICHD NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>2518-28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3396784</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(8)</volume><pubmed_abstract>Male rats transgenic for HLA-B27 and human ?(2) -microglobulin (h?(2) m) spontaneously develop epididymoorchitis (EO) preceding the development of spondylarthritis (SpA). In the specific B27/h?(2) m-transgenic rat cross-strain (21-3 × 382-2)F(1) , only the males develop SpA, and neither sex develops gut inflammation. This study was undertaken to determine whether EO and SpA in male (21-3 × 382-2)F(1)  rats are causally related. In addition, the primary characteristics of EO in this rat arthritis model were assessed.Male B27/h?(2) m-transgenic (21-3 × 382-2)F(1)  rats underwent bilateral, unilateral, or sham epididymoorchiectomy between ages 36 and 125 days. The castrated rats were given testosterone replacement. Alternatively, the 21-3 and 283-2 transgene loci were crossed with a transgene inducing aspermatogenesis. Rats were observed for the development of EO, arthritis, and spondylitis.In unmanipulated transgenic rats, inflammation was first evident in the ductuli efferentes (DE; ducts linking the rete testis to epididymis) as early as age 30 days. The inflammation was initially neutrophilic, and later became granulomatous. Antisperm and anti-testis cell antibodies appeared in the rat serum after age 70 days. Cells infiltrating the testes were predominantly CD4+ T cells and CD68+ or CD163+ macrophages. Quantitative polymerase chain reaction of the DE, epididymis, and testis showed elevations in the levels of interferon-?, interleukin-10 (IL-10), and IL-17A. In addition, levels of IL-12A, IL-22, IL-23A, and IL-23 receptor were found to be elevated in the DE. Remarkably, castration of the rats before age 91 days completely prevented the subsequent onset of arthritis and spondylitis, as did transgene-induced azospermia.Autoimmune EO develops spontaneously in HLA-B27/h?(2) m-transgenic (21-3 × 283-2)F(1)  rats at age 30 days, the age when antigen-positive meiotic germ cells first exit the testis. Persistent testicular inflammation and/or antigenic stimulation are essential prerequisites for the subsequent development of SpA. Thus, dysregulated innate immunity at immune-privileged sites may be an essential mechanism triggering the onset of SpA.</pubmed_abstract><journal>Arthritis and rheumatism</journal><pubmed_title>Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic rats.</pubmed_title><pmcid>PMC3396784</pmcid><funding_grant_id>R01 AI041236-18</funding_grant_id><funding_grant_id>R01-AI-41236</funding_grant_id><funding_grant_id>R01 AR038319</funding_grant_id><funding_grant_id>R01 HD053889</funding_grant_id><funding_grant_id>R01 AR038319-21</funding_grant_id><funding_grant_id>R01 AI041236</funding_grant_id><funding_grant_id>R01-AR-38319</funding_grant_id><funding_grant_id>R01 HD061575</funding_grant_id><pubmed_authors>van Duivenvoorde LM</pubmed_authors><pubmed_authors>Dorris ML</pubmed_authors><pubmed_authors>Sun M</pubmed_authors><pubmed_authors>Hammer RE</pubmed_authors><pubmed_authors>Tung KS</pubmed_authors><pubmed_authors>Rival C</pubmed_authors><pubmed_authors>Hamra FK</pubmed_authors><pubmed_authors>Richardson JA</pubmed_authors><pubmed_authors>Shelton JM</pubmed_authors><pubmed_authors>Taurog JD</pubmed_authors><pubmed_authors>Satumtira N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic rats.</name><description>Male rats transgenic for HLA-B27 and human ?(2) -microglobulin (h?(2) m) spontaneously develop epididymoorchitis (EO) preceding the development of spondylarthritis (SpA). In the specific B27/h?(2) m-transgenic rat cross-strain (21-3 × 382-2)F(1) , only the males develop SpA, and neither sex develops gut inflammation. This study was undertaken to determine whether EO and SpA in male (21-3 × 382-2)F(1)  rats are causally related. In addition, the primary characteristics of EO in this rat arthritis model were assessed.Male B27/h?(2) m-transgenic (21-3 × 382-2)F(1)  rats underwent bilateral, unilateral, or sham epididymoorchiectomy between ages 36 and 125 days. The castrated rats were given testosterone replacement. Alternatively, the 21-3 and 283-2 transgene loci were crossed with a transgene inducing aspermatogenesis. Rats were observed for the development of EO, arthritis, and spondylitis.In unmanipulated transgenic rats, inflammation was first evident in the ductuli efferentes (DE; ducts linking the rete testis to epididymis) as early as age 30 days. The inflammation was initially neutrophilic, and later became granulomatous. Antisperm and anti-testis cell antibodies appeared in the rat serum after age 70 days. Cells infiltrating the testes were predominantly CD4+ T cells and CD68+ or CD163+ macrophages. Quantitative polymerase chain reaction of the DE, epididymis, and testis showed elevations in the levels of interferon-?, interleukin-10 (IL-10), and IL-17A. In addition, levels of IL-12A, IL-22, IL-23A, and IL-23 receptor were found to be elevated in the DE. Remarkably, castration of the rats before age 91 days completely prevented the subsequent onset of arthritis and spondylitis, as did transgene-induced azospermia.Autoimmune EO develops spontaneously in HLA-B27/h?(2) m-transgenic (21-3 × 283-2)F(1)  rats at age 30 days, the age when antigen-positive meiotic germ cells first exit the testis. Persistent testicular inflammation and/or antigenic stimulation are essential prerequisites for the subsequent development of SpA. Thus, dysregulated innate immunity at immune-privileged sites may be an essential mechanism triggering the onset of SpA.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Aug</publication><modification>2020-10-29T11:58:06Z</modification><creation>2019-03-27T00:55:38Z</creation></dates><accession>S-EPMC3396784</accession><cross_references><pubmed>22488218</pubmed><doi>10.1002/art.34480</doi></cross_references></HashMap>